Search research articles
Contact Us
Filters
Showing results (861-870 of 1,298) with videos related to
Page
of 130
Sort By:
Oncogene
|
April 19, 2011
Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition
B N Rexer, A-J L Ham, C Rinehart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2018
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells
Fiona Simpkins, Kibeom Jang, Hyunho Yoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2021
Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer
Argun Akcakanat, Xiaofeng Zheng, Christian X Cruz Pico, et al.
Cancer Cell
|
March 15, 2006
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages
Barbara Visentin, John A Vekich, Bradley J Sibbald, et al.
Cancer Cell
|
October 7, 2014
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors
Lydia W T Cheung, Shuangxing Yu, Dong Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 27, 2011
EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF
Gabi Tarcic, Roi Avraham, Gur Pines, et al.
Breast Cancer Research and Treatment
|
July 10, 2016
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion
Abhijit Mazumdar, Graham M Poage, Jonathan Shepherd, et al.
Oncogene
|
August 26, 2014
hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness
M J Choi, K H Cho, S Lee, et al.
Cancer Research
|
February 16, 2021
MEK Inhibition Remodels the Immune Landscape of Mutant <i>KRAS</i> Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors
Bin Yang, Xi Li, Yu Fu, et al.
Molecular Cancer
|
June 10, 2010
Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid
Molly K Altman, Vashisht Gopal, Wei Jia, et al.
Page
of 130
Search research articles
Search
Showing results (861-870 of 1,298) with videos related to
Sort By:
Page
of 130
Oncogene
|
April 19, 2011
Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition
B N Rexer, A-J L Ham, C Rinehart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2018
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells
Fiona Simpkins, Kibeom Jang, Hyunho Yoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2021
Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer
Argun Akcakanat, Xiaofeng Zheng, Christian X Cruz Pico, et al.
Cancer Cell
|
March 15, 2006
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages
Barbara Visentin, John A Vekich, Bradley J Sibbald, et al.
Cancer Cell
|
October 7, 2014
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors
Lydia W T Cheung, Shuangxing Yu, Dong Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 27, 2011
EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF
Gabi Tarcic, Roi Avraham, Gur Pines, et al.
Breast Cancer Research and Treatment
|
July 10, 2016
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion
Abhijit Mazumdar, Graham M Poage, Jonathan Shepherd, et al.
Oncogene
|
August 26, 2014
hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness
M J Choi, K H Cho, S Lee, et al.
Cancer Research
|
February 16, 2021
MEK Inhibition Remodels the Immune Landscape of Mutant <i>KRAS</i> Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors
Bin Yang, Xi Li, Yu Fu, et al.
Molecular Cancer
|
June 10, 2010
Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid
Molly K Altman, Vashisht Gopal, Wei Jia, et al.
Page
of 130